Compare AMRN & PNNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AMRN | PNNT |
|---|---|---|
| Founded | 1989 | 2007 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 287.9M | 251.4M |
| IPO Year | 1998 | 2007 |
| Metric | AMRN | PNNT |
|---|---|---|
| Price | $14.04 | $3.54 |
| Analyst Decision | Strong Sell | Hold |
| Analyst Count | 1 | 5 |
| Target Price | ★ $12.00 | $5.75 |
| AVG Volume (30 Days) | 79.6K | ★ 472.1K |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 20.87% |
| EPS Growth | ★ 55.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $181,104,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.26 | N/A |
| P/E Ratio | ★ N/A | $13.14 |
| Revenue Growth | ★ 39.22 | N/A |
| 52 Week Low | $12.96 | $3.19 |
| 52 Week High | $20.90 | $7.06 |
| Indicator | AMRN | PNNT |
|---|---|---|
| Relative Strength Index (RSI) | 47.17 | 42.54 |
| Support Level | $13.59 | $3.31 |
| Resistance Level | $14.55 | $3.59 |
| Average True Range (ATR) | 0.54 | 0.09 |
| MACD | 0.03 | -0.03 |
| Stochastic Oscillator | 36.25 | 6.45 |
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States.
Pennant Park Investment Corp is a closed-end, non-diversified investment company. Its investment objective is to generate current income and capital appreciation also seeking to preserve capital through debt and equity investments. The company focuses on investing in United States middle-market companies that offer attractive risk-reward to investors and to create a diversified portfolio that includes senior secured debt, mezzanine debt, and equity investments. It generates majority of its revenue from interest and dividends received from investments made.